Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at URI's multiple
$3.707.3% below market
0.94 ZNTL revenue / share×3.93x URI P/S=$3.70
Market $3.99Implied $3.70
URI · current priceP/S 3.93x
$1,009.86Latest market snapshot
Implied fair value · at ZNTL's multiple
$1,089.947.9% above market
256.98 URI revenue / share×4.24x ZNTL P/S=$1,089.94
Market $1,009.86Implied $1,089.94